9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Estimated reading time: < 1 min

Condition: Esophageal Cancer

Estimated Enrollment:

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: ,  ,  ,

Interventions: decitabine,

Phase:

Study Type: Interventional

Study Design: Primary Purpose: Treatment, , ,

Primary Completion Date:

Completion Date:

Last  Posted Date: April 29, 2015

Location: Warren Grant Magnuson Clinical Center – NCI Clinical Studies Support, Bethesda, Maryland, United States

Website Link: https://ClinicalTrials.gov/show/NCT00019825

Was this article helpful?
Dislike 0